For instance, the serine protease inhibitor SERPINB3 is upregulated in AD patients, where its expression correlates with skin inflammation and returns to baseline levels in non-inflamed skin upon treatment (Kawashima et al., 2000; Mitsuishi et al., 2005). This evidence concerns the gene SERPINB3 and Alzheimer disease.